Account

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 195(29), E987, 2023

Don't ignore perimenopause

Christine L Hitchcock , Jerilynn C Prior , Sonia Shirin

Author affiliations (3)
  • Centre for Menstrual Cycle and Ovulation Research, Division of Endocrinology, University of British Columbia, Vancouver, BC, Canada. ROR
  • Vancouver Hospital and Health Sciences Centre ROR
  • Women's Health Research Institute ROR
DOI10.1503/cmaj.148952-l PMID37524397
Read at publisher

Abstract

We agree with Lega and colleagues[1][1] that menopausal hormone therapy (MHT) has been shown in randomized controlled trials (RCTs) to be effective and safe for treating problematic vasomotor symptoms related to menopause. We also agree that treating menopausal vasomotor symptoms is important to

Topics

Perimenopause/MenopauseReproductive Endocrinology
perimenopause management, menopausal hormone therapy, vasomotor symptoms treatment, progesterone therapy perimenopause, hot flushes perimenopausal, ovarian aging, estradiol decline, menstrual cycle changes perimenopause, randomized controlled trials hormone therapy, cyclic progesterone
PMID 37524397 37524397 DOI 10.1503/cmaj.148952-l 10.1503/cmaj.148952-l

Cite this article

Prior, J. C., Hitchcock, C. L., Shirin, S., Hale, G., & Goshtasebi, A. (2023). Don't ignore perimenopause. *CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne*, *195*(29), E987. https://doi.org/10.1503/cmaj.148952-l

Related articles

The importance of estradiol for body weight regulation in women
Vigil P et al. 2022 Open Access Frontiers in Endocrinology

Obesity in women of reproductive age has a number of adverse metabolic effects, including Type II Diabetes (T2D), dyslipidemia, and cardiovascular disease. It is associated with increased menstrual ir...

Reproductive EndocrinologyPerimenopause/Menopause